Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CNPY4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RAP1GAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
UBE2D4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SAMD9L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LITAF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIPEP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TFDP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NFIB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C17orf97 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF135 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BLVRB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AFDN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GBP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VDAC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on